1-97098577-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_000110.4(DPYD):āc.2678A>Gā(p.Asn893Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_000110.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYD | NM_000110.4 | c.2678A>G | p.Asn893Ser | missense_variant | 21/23 | ENST00000370192.8 | NP_000101.2 | |
DPYD-AS1 | NR_046590.1 | n.64+2591T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYD | ENST00000370192.8 | c.2678A>G | p.Asn893Ser | missense_variant | 21/23 | 1 | NM_000110.4 | ENSP00000359211 | P1 | |
DPYD-AS1 | ENST00000422980.1 | n.64+2591T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250708Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135482
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460980Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 726800
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 31, 2024 | Variant summary: DPYD c.2678A>G (p.Asn893Ser) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.7e-05 in 1606262 control chromosomes, predominantly at a frequency of 0.0013 within the East Asian subpopulation in the gnomAD database (v4.1 dataset). In addition, the variant was reported with an allele frequency of 0.0022 (i.e. 235 / 108520 alleles; no homozygotes), in healthy Japanese individuals in the jMorp database (PMID: 33179747). This frequency is close to the estimated maximum expected for a pathogenic variant in DPYD causing Dihydropyrimidine Dehydrogenase Deficiency (0.0025), suggesting that the variant might be benign. The variant, c.2678A>G, has been reported in the literature in Japanese individuals (e.g. Maekawa_2007), and at least two colon cancer patients were described who did not develop severe fluoropyrimidine-related toxicities (Kanai_2023). Publications also reported experimental evidence evaluating an impact on protein function, and demonstrated that the variant resulted in a mild decrease in enzyme activity, corresponding to about 80% residual activity relative to the WT (Offer_2013), while a later study found that the variant N893S exhibited significantly lower activity, corresponding to ~62.8% of the WT (Hishinuma_2018). The following publications have been ascertained in the context of this evaluation (PMID: 17828463, 36524458, 23328581, 29769267, 29152729). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at